ARROWHEAD PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25 USD | -0.16% |
|
-0.87% | -18.30% |
| 05-10 | UBS Cuts Price Target on Arrowhead Pharmaceuticals to $71 From $75, Keeps Buy Rating | MT |
| 05-09 | Arrowhead Pharmaceuticals Swings to Loss in Fiscal Q2 | MT |